Miglustat
NDC 70710-2039, Miglustat, capsule, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-2039
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219111
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2039 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MIGLUSTAT100 mg/1
Pharmacologic classes
Enzyme Stabilizer [EPC]; Enzyme Stabilizers [MoA]; Glucosylceramide Synthase Inhibitor [EPC]; Glucosylceramide Synthase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-2039-8 | 70710203908 | 6 BLISTER PACK in 1 CARTON (70710-2039-8) / 15 CAPSULE in 1 BLISTER PACK (70710-2039-4) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b54cc8a0-2284-44c3-a8fa-d8aaa87a67c6
Use it
Look up 70710-2039 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2039 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-2039. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.